C
Cydar Medical
AI-powered surgical intelligence maps for endovascular procedures
About Cydar Medical
Cydar Medical is a pioneering company in the healthcare technology sector, specializing in advanced imaging software for surgical guidance. Their flagship product delivers automated 3D overlays into the operating room, which significantly aids surgeons during procedures. This technology is particularly beneficial in endovascular interventions, where it can reduce procedure times by 30 to 60 minutes and decrease radiation exposure by up to 50%. Additionally, the use of 3D maps helps lower the dose of nephrotoxic iodinated contrast, improving renal function in patients.
Read full description
Cydar Medical's clients primarily include hospitals and surgical centers that perform complex surgeries, especially those involving vascular systems. The company operates in the medical technology market, focusing on innovations that enhance surgical precision and patient outcomes. Their business model revolves around selling and licensing their proprietary software to healthcare institutions. They generate revenue through direct sales, subscription models, and potentially through partnerships with medical device manufacturers.
The company's technology is powered by artificial intelligence (AI), which allows for dynamic adjustments during surgeries. This means the software can adapt to changes in a patient's anatomy in real-time, providing surgeons with the most accurate and up-to-date information. This not only makes surgeries safer and less invasive but also reduces the cognitive load on surgeons, allowing them to focus more on the procedure itself.
Cydar Medical's innovative approach is protected by international patents, ensuring their competitive edge in the market. They are continually looking to expand their team and develop new products that leverage cloud computing, further enhancing the capabilities of their surgical guidance systems.
At a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Cambridge, United Kingdom
- Employees
- 39
- Open positions
- None listed
- Dealroom signal
- 69.6/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, X-Ray
- Technology
- Artificial Intelligence, 3D Technology, Big Data, Deep Tech, Machine Learning, Computer Vision
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jun 2025 | $12M | $61M | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Feb 2023 | $12M | $49M | Pembroke VCT · Downing | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Cydar Medical is 440 monthly website visits, down 41.3% over the last three months. Cydar Medical's team declined 7.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Pembroke VCT
Downing
Other known investors7 additional known investors
King's College London
Crista Galli Ventures
European Innovation Council- GWGWC
Morningside
Venture Founders
VentureFounders
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cydar Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cydar Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.